Company page

Tempest Therapeutics, Inc.

Tempest Therapeutics, Inc. (TPST) is a public company based in the United States with a market capitalization of approximately $18.2 million. The company focuses on developing innovative therapies for cancer treatment. As a publicly traded entity, it operates within the American market, providing investors with opportunities to engage in its growth and developments.